Pharmacological Guidelines for Treating PTSD

At FTS Academy Courses, your satisfaction with our courses and process is very important to us. All Course units for this Course are free to view and download. You only pay, when you are ready for the Final exam. That will unlock both the Exam and the Certificate of Completion. Detailed information on reviewing your results, evaluation and printing your certificate are explained as well, once you unlock the exam and certificate.

For a brief overview of the process:
please feel free to view our “How FTS Works” page.

To get started with the course:
please select “CURRICULUM” from the left hand sidebar. From there you will see all the course units and sections.

Brief Description: 2 CEU Course

The co-occurrence of PTSD and co-occurring opioid use disorders was selected for guideline development because of the high rates of trauma in substance users and high rates of PTSD amongst those with substance use disorders. The lifetime prevalence of PTSD in adults in the United States is approximately 7 percent, and past year prevalence is about 4 percent. The lifetime prevalence of PTSD among women (9.7%) is 2.5 times that of men (3.6%), and the 12-month prevalence for women (5.2%) is nearly three times that of men (1.8%). Veterans have a greater prevalence of PTSD than the general population. Lifetime prevalence for Vietnam veterans is 30.9 percent for men and 26.9 percent for women, with current prevalence of 15.2 percent for men and 8.1 percent for women.
Veterans from the Afghanistan and Iraq wars have a current PTSD prevalence of approximately 14 percent. Among those with PTSD, substance use disorders occur in 21-43 percent of the population. In those with substance use disorders, lifetime prevalence of PTSD ranges from 26-52 percent, and current PTSD ranges from 15-41 percent.